表紙
市場調查報告書

全球IVD感染疾病市場規模,佔有率,趨勢分析:實驗部位,各產品,各用途,各技術(免疫化學,分子診斷),市場區隔預測

Infectious Diseases In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics), By End Use, By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 818719
出版日期 內容資訊 英文 185 Pages
商品交期: 2-3個工作天內
價格
全球IVD感染疾病市場規模,佔有率,趨勢分析:實驗部位,各產品,各用途,各技術(免疫化學,分子診斷),市場區隔預測 Infectious Diseases In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics), By End Use, By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年02月17日內容資訊: 英文 185 Pages
簡介

本報告提供全球IVD感染疾病市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 市場變數,趨勢,範圍

  • 市場直線預測
  • 滲透度與成長預測製圖
  • 法律規章架構
  • 市場趨勢
    • 推動市場的要素分析
    • 阻礙市場的要素分析
  • 市場分析工具

第4章 競爭分析

  • 近幾年的發展及影響分析
  • 企業/競爭分類
  • 供應商環境
  • 公共企業
  • 民營企業

第5章 各產品市場預測與趨勢分析

  • 定義和範圍
  • 市場趨勢
  • 市場規模與預測,趨勢分析
    • 計量儀器
    • 試劑
    • 軟體
  • 各用途產品市場

第6章 各技術市場預測與趨勢分析

  • 定義和範圍
  • 市場佔有率
  • 市場概要
  • 市場規模與預測,趨勢分析
    • 免疫化學
    • 分子診斷
    • 微生物學
    • 其他

第7章 各用途費市場預測與趨勢分析

  • 定義和範圍
  • 市場佔有率
  • 市場概要
  • 市場規模與預測,趨勢分析
    • MRSA
    • 難治梭狀芽胞桿菌
    • 萬古霉素抗藥性腸球菌
    • 耐碳青黴烯類細菌檢驗
    • 呼吸系統病毒
    • 念珠菌
    • 結核·抗藥性結核菌
    • 胃腸道檢驗
    • 披衣菌感染
    • 淋病
    • HPV
    • HIV
    • C型肝炎
    • B型肝炎
    • 其他

第8章 各實驗部位市場預測與趨勢分析

  • 定義和範圍
  • 市場佔有率
  • 市場概要
  • 市場規模與預測,趨勢分析
    • 照護現場
    • 中央實驗室
    • 其他

第9章 各地區預測與趨勢分析

  • 各地區趨勢分析
  • 主要企業
  • SWOT分析
  • 市場規模與預測,趨勢分析
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第10章 競爭環境

  • 策略架構
  • 民營企業的熱圖分析

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 978-1-68038-716-2

The global infectious diseases in vitro diagnostics market size is estimated to reach USD 33.1 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 6.3% over the forecast period. Growing geriatric population and increased consumer awareness regarding the advantages of in-vitro diagnostics (IVD) tests are anticipated to drive the market growth.

With advancements in in-vitro diagnostics, a subsequent demand has been witnessed for improved diagnosis in terms of precision, accuracy, speed, and specificity. New-age diagnostics are leading to a marked decline in sales of old products that are not at par. Moreover, although most diagnostics are specific to an application, upcoming diagnostic products would be able to test and confirm multiple related diseases, thus saving time and money. Technological advancements in the field of biomarkers are also a significant driver for this market.

Presence of various e-commerce sites offering diagnostic kits, especially Point of Care (PoC) devices, is expected to drive the sales of the products through this sales channel. Several manufacturers are selling IVD kits via e-commerce channels that provide the added benefits of discounts, warranty, and prompt customer service. In addition, some e-commerce sites offer insurance on these products which also provide an additional advantage to the buyers.

Moreover, the regulatory and reimbursement landscape is continually evolving to adapt to the fast-paced research progress in this sector. Proactive initiatives by public and private organizations to raise consumer awareness about infectious diseases and treatment modalities are expected to drive the market growth in the coming years.

Further key findings from the report suggest:

  • Technological advancements related to accuracy, portability, and cost-effectiveness are expected to be high impact rendering drivers for the market
  • Growing awareness and increasing dependency of healthcare practitioners on the usage of point-of-care diagnostic enabled medical devices and consumables are expected to drive the IVD infectious diseases market growth over the forecast period
  • Key applications of immunochemistry include detection of infectious microorganisms such as virus, bacteria, and fungus and their toxins and coat antigens
  • Development of techniques such as Polymerase Chain Reaction (PCR) and in-situ hybridization is expected to boost the molecular diagnostics segment over the forecast period
  • Key players include bioMerieux SA; BD; Abbott; Quidel Corporation; F. Hoffmann-La Roche Ltd.; Alere Inc.; Cepheid; Hologic Inc.; Qiagen N.V.; Orasure Technologies, Inc.; Bio-Rad Laboratories, Inc.; and Siemens Healthcare GmbH.

Table of Contents

Chapter 1 Methodology and Scope

      • 1.1.Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources & third party perspectives
    • 1.3.4. Primary research
  • 1.4. Information Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. IVD Infectious Diseases Market Variables, Trends & Scope

  • 3.1. IVD Infectious Diseases Market Lineage outlook
    • 3.1.1. IVD market outlook
    • 3.1.2. Infectious diseases market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Regulatory Framework
    • 3.3.1. Reimbursement framework
    • 3.3.2. Standards & compliances
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
      • 3.4.1.1. Growing geriatric population base
      • 3.4.1.2. Technological advancements
      • 3.4.1.3. High demand for point of care facilities
      • 3.4.1.4. Increasing prevalence of infectious diseases
      • 3.4.1.5. External funding for R&D activities
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. Ambiguous regulatory framework
      • 3.4.2.2 High prices of IVD diagnostic tests
  • 3.5. IVD Infectious Diseases Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power: (Low due to large number of diagnostic test manufacturers)
      • 3.5.1.2. Buyer power: (Low due to high market demand)
      • 3.5.1.3. Substitution threat: (Low due to no/less external substitutes)
      • 3.5.1.4. Threat from new entrant: (Moderate due to existing brand recognition)
      • 3.5.1.5. Competitive rivalry: (High due to mergers & acquisitions by major players)
    • 3.5.2. PESTEL analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Environmental landscape
      • 3.5.2.3. Social landscape
      • 3.5.2.4. Technology landscape
      • 3.5.2.5. Legal landscape
    • 3.5.3. Major deals & strategic alliances analysis
      • 3.5.3.1. Joint ventures
      • 3.5.3.2. Mergers & acquisitions
      • 3.5.3.3. Licensing & partnership
      • 3.5.3.4. Technology collaborations
      • 3.5.3.5. Strategic divestments

Chapter 4. IVD Infectious Diseases Market - Competitive Analysis

  • 4.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2. Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
  • 4.3. Vendor Landscape
    • 4.3.1. List of key distributors and channel partners
    • 4.3.2. Key company market share analysis, 2019
  • 4.4. Public Companies
    • 4.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 4.4.2. Company market share
    • 4.4.3. Competitive dashboard analysis
    • 4.4.4. Market differentiators
    • 4.4.5. Synergy analysis: Major deals & strategic alliances
  • 4.5. Private Companies
    • 4.5.1. List of key emerging companies
    • 4.5.2. Regional network map
    • 4.5.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)

Chapter 5. IVD Infectious Diseases Market: Product Estimates & Trend Analysis

  • 5.1. Definitions & Scope
  • 5.2. IVD Infectious Diseases Market, by Product, 2015 to 2027
  • 5.3. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
    • 5.3.1. Instruments
      • 5.3.1.1 Instrument IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 5.3.2. Reagents
      • 5.3.2.1 Reagents IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 5.3.3. Software
      • 5.3.3.1 Software IVD infectious diseases market, 2015 - 2027 (USD Million)
  • 5.4. Product Markets, by Application, 2015 - 2027:
    • 5.4.1. Instruments
      • 5.4.1.1 MRSA
      • 5.4.1.1.1 Instruments IVD market, by MRSA, 2015 - 2027 (USD Million)
      • 5.4.1.2 Streptococcus
      • 5.4.1.2.1 Instruments IVD market, by Streptococcus, 2015 - 2027 (USD Million)
      • 5.4.1.3 Clostridium difficile
      • 5.4.1.3.1 Instruments IVD market, by Clostridium difficile, 2015 - 2027 (USD Million)
      • 5.4.1.4 Vancomycin resistance enterococci
      • 5.4.1.4.1 Instruments IVD market, by VRE, 2015 - 2027 (USD Million)
      • 5.4.1.5 Carbapenem resistant bacterial testing
      • 5.4.1.5.1 Instruments IVD market, by CRE, 2015 - 2027 (USD Million)
      • 5.4.1.6 Respiratory virus
      • 5.4.1.6.1 Instruments IVD market, by Respiratory virus, 2015 - 2027 (USD Million)
      • 5.4.1.7 Candida
      • 5.4.1.7.1 Instruments IVD market, by Candida, 2015 - 2027 (USD Million)
      • 5.4.1.8 Tuberculosis and drug-resistant tuberculosis
      • 5.4.1.8.1 Instruments IVD market, by TB and drug-resistant TB, 2015 - 2027 (USD Million)
      • 5.4.1.9 Gastrointestinal panel testing
      • 5.4.1.9.1 Instruments IVD market, by GI panel testing, 2015 - 2027 (USD Million)
      • 5.4.1.10 Chlamydia
      • 5.4.1.10.1 Instruments IVD market, by Chlamydia, 2015 - 2027 (USD Million)
      • 5.4.1.11 Gonorrhea
      • 5.4.1.11.1 Instruments IVD market, by Gonorrhea, 2015 - 2027 (USD Million)
      • 5.4.1.12 HPV
      • 5.4.1.12.1 Instruments IVD market, by HPV, 2015 - 2027 (USD Million)
      • 5.4.1.13 HIV
      • 5.4.1.13.1 Instruments IVD market, by HIV, 2015 - 2027 (USD Million)
      • 5.4.1.14 Hepatitis C
      • 5.4.1.14.1 Instruments IVD market, by Hepatitis C, 2015 - 2027 (USD Million)
      • 5.4.1.15 Hepatitis B
      • 5.4.1.15.1 Instruments IVD market, by Hepatitis B, 2015 - 2027 (USD Million)
    • 5.4.2. Reagents
      • 5.4.2.1 MRSA
      • 5.4.2.1.1 Reagents IVD market, by MRSA, 2015 - 2027 (USD Million)
      • 5.4.2.2 Streptococcus
      • 5.4.2.2.1 Reagents IVD market, by Streptococcus, 2015 - 2027 (USD Million)
      • 5.4.2.3 Clostridium difficile
      • 5.4.2.3.1 Reagents IVD market, by Clostridium difficile, 2015 - 2027 (USD Million)
      • 5.4.2.4 Vancomycin resistance enterococci
      • 5.4.2.4.1 Reagents IVD market, by VRE, 2015 - 2027 (USD Million)
      • 5.4.2.5 Carbapenem resistant bacterial testing
      • 5.4.2.5.1 Reagents IVD market, by CRE, 2015 - 2027 (USD Million)
      • 5.4.2.6 Respiratory virus
      • 5.4.2.6.1 Reagents IVD market, by Respiratory virus, 2015 - 2027 (USD Million)
      • 5.4.2.7 Candida
      • 5.4.2.7.1 Reagents IVD market, by Candida, 2015 - 2027 (USD Million)
      • 5.4.2.8 Tuberculosis and drug-resistant tuberculosis
      • 5.4.2.8.1 Reagents IVD market, by TB and drug-resistant TB, 2015 - 2027 (USD Million)
      • 5.4.2.9 Gastrointestinal panel testing
      • 5.4.2.9.1 Reagents IVD market, by GI panel testing, 2015 - 2027 (USD Million)
      • 5.4.2.10 Chlamydia
      • 5.4.2.10.1 Reagents IVD market, by Chlamydia, 2015 - 2027 (USD Million)
      • 5.4.2.11 Gonorrhea
      • 5.4.2.11.1 Reagents IVD market, by Gonorrhea, 2015 - 2027 (USD Million)
      • 5.4.2.12 HPV
      • 5.4.2.12.1 Reagents IVD market, by HPV, 2015 - 2027 (USD Million)
      • 5.4.2.13 HIV
      • 5.4.2.13.1 Reagents IVD market, by HIV, 2015 - 2027 (USD Million)
      • 5.4.2.14 Hepatitis C
      • 5.4.2.14.1 Reagents IVD market, by Hepatitis C, 2015 - 2027 (USD Million)
      • 5.4.2.15 Hepatitis B
      • 5.4.2.15.1 Reagents IVD market, by Hepatitis B, 2015 - 2027 (USD Million)
    • 5.4.3. Software
      • 5.4.3.1 MRSA
      • 5.4.3.1.1 Software IVD market, by MRSA, 2015 - 2027 (USD Million)
      • 5.4.3.2 Streptococcus
      • 5.4.3.2.1 Software IVD market, by Streptococcus, 2015 - 2027 (USD Million)
      • 5.4.3.3 Clostridium difficile
      • 5.4.3.3.1 Software IVD market, by Clostridium difficile, 2015 - 2027 (USD Million)
      • 5.4.3.4 Vancomycin resistance enterococci
      • 5.4.3.4.1 Software IVD market, by VRE, 2015 - 2027 (USD Million)
      • 5.4.3.5 Carbapenem resistant bacterial testing
      • 5.4.3.5.1 Software IVD market, by CRE, 2015 - 2027 (USD Million)
      • 5.4.3.6 Respiratory virus
      • 5.4.3.6.1 Software IVD market, by Respiratory virus, 2015 - 2027 (USD Million)
      • 5.4.3.7 Candida
      • 5.4.3.7.1 Software IVD market, by Candida, 2015 - 2027 (USD Million)
      • 5.4.3.8 Tuberculosis and drug-resistant tuberculosis
      • 5.4.3.8.1 Software IVD market, by TB and drug-resistant TB, 2015 - 2027 (USD Million)
      • 5.4.3.9 Gastrointestinal panel testing
      • 5.4.3.9.1 Software IVD market, by GI panel testing, 2015 - 2027 (USD Million)
      • 5.4.3.10 Chlamydia
      • 5.4.3.10.1 Software IVD market, by Chlamydia, 2015 - 2027 (USD Million)
      • 5.4.3.11 Gonorrhea
      • 5.4.3.11.1 Software IVD market, by Gonorrhea, 2015 - 2027 (USD Million)
      • 5.4.3.12 HPV
      • 5.4.3.12.1 Software IVD market, by HPV, 2015 - 2027 (USD Million)
      • 5.4.3.13 HIV
      • 5.4.3.13.1 Software IVD market, by HIV, 2015 - 2027 (USD Million)
      • 5.4.3.14 Hepatitis C
      • 5.4.3.14.1 Software IVD market, by Hepatitis C, 2015 - 2027 (USD Million)
      • 5.4.3.15 Hepatitis B
      • 5.4.3.15.1 Software IVD market, by Hepatitis B, 2015 - 2027 (USD Million)

Chapter 6. IVD Market: Technology Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. Technology Market Share Analysis, 2019 & 2027
  • 6.3. IVD Infectious Diseases Market, by Technology, 2015 to 2027
  • 6.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
    • 6.4.1. Immunochemistry
      • 6.4.1.1 Immunochemistry IVD Infectious Diseases Market, 2015 - 2027 (USD Million)
    • 6.4.2. Molecular Diagnostics
      • 6.4.2.1 Molecular diagnostics IVD Infectious Diseases Market, 2015 - 2027 (USD Million)
    • 6.4.3. Microbiology
      • 6.4.3.1 Microbiology IVD Infectious Diseases Market, 2015 - 2027 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1 Other IVD Infectious Diseases Market, 2015 - 2027 (USD Million)

Chapter 7. IVD Market: Application Estimates & Trend Analysis

  • 7.1. Definitions & Scope
  • 7.2. Application Market Share Analysis, 2019 & 2027
  • 7.3. IVD Infectious Diseases Market, by Application, 2015 to 2027
  • 7.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
    • 7.4.1. MRSA
      • 7.4.1.1 MRSA IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.2. Streptococcus
      • 7.4.2.1 Streptococcus IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.3. Clostridium difficile
      • 7.4.3.1 Clostridium difficile IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.4. Vancomycin resistant enterococci
      • 7.4.4.1 VRE IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.5. Carbapenem resistant bacterial testing
      • 7.4.5.1 CRE IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.6. Respiratory virus
      • 7.4.6.1 Respiratory virus IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.7. Candida
      • 7.4.7.1 Candida IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.8. Tuberculosis and drug-resistant tuberculosis
      • 7.4.8.1 TB and drug-resistant TB IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.9. Gastrointestinal panel testing
      • 7.4.9.1 GI panel testing IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.10. Chlamydia
      • 7.4.10.1 Chlamydia IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.11. Gonorrhea
      • 7.4.11.1 Gonorrhea IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.12. HPV
      • 7.4.12.1 HPV IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.13. HIV
      • 7.4.13.1 HIV IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.14. Hepatitis C
      • 7.4.14.1 Hepatitis C IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.15. Hepatitis B
      • 7.4.15.1 Hepatitis B IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 7.4.16. Others
      • 7.4.16.1 Others IVD infectious diseases market, 2015 - 2027 (USD Million)

Chapter 8. IVD Market: End Use Estimates & Trend Analysis

  • 8.1. Definitions & Scope
  • 8.2. End use market share analysis, 2019 & 2027
  • 8.3. IVD Infectious Diseases Market, by End Use, 2015 to 2027
  • 8.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
    • 8.4.1. Point of Care
      • 8.4.1.1 Point of Care IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 8.4.2. Central laboratories
      • 8.4.2.1 Central laboratories IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 8.4.3. Others
      • 8.4.3.1 Others IVD infectious diseases market, 2015 - 2027 (USD Million)

Chapter 9 IVD Market: Regional Estimates & Trend Analysis, by Product, Technology, Application, & End Use

  • 9.1 IVD Infectious Diseases Market: Regional Movement Analysis, 2019 & 2027
  • 9.2 IVD Infectious Diseases Market: Leading Players, 2019:
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa
  • 9.4 North America
    • 9.4.1 North America IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.4.2 U.S.
      • 9.4.2.1 U.S. IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.4.3 Canada
      • 9.4.3.1 Canada IVD infectious diseases market, 2015 - 2027 (USD Million)
  • 9.5. Europe
    • 9.5.1 Europe IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.5.2 U.K.
      • 9.5.2.1 U.K. IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.5.3 Germany
      • 9.5.3.1 Germany IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.5.4 Spain
      • 9.5.4.1 Spain IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.5.5 France
      • 9.5.4.1 France IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.5.6 Italy
      • 9.5.6.1 Italy IVD infectious diseases market, 2015 - 2027 (USD Million)
  • 9.6 Asia Pacific
    • 9.6.1 Asia Pacific IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.6.2 Japan
      • 9.6.2.1 Japan IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.6.3 India
      • 9.6.3.1 India IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.6.4 South Korea
      • 9.6.4.1 South Korea IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.6.5 China
      • 9.6.5.1 China IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.6.6 Australia
      • 9.6.6.1 Australia IVD infectious diseases market, 2015 - 2027 (USD Million)
  • 9.7 Latin America
    • 9.7.1 Latin America IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.7.2 Brazil
      • 9.7.2.1 Brazil IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.7.3 Mexico
      • 9.7.3.1 Mexico IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.7.4 Argentina
      • 9.7.4.1 Argentina IVD infectious diseases market, 2015 - 2027 (USD Million)
  • 9.8 MEA
    • 9.8.1 MEA IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.8.2 South Africa
      • 9.8.2.1 South Africa IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.8.3 U.A.E.
      • 9.8.3.1 U.A.E. IVD infectious diseases market, 2015 - 2027 (USD Million)
    • 9.8.4 Saudi Arabia
      • 9.8.4.1 Saudi Arabia IVD infectious diseases market, 2015 - 2027 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Strategy Framework
  • 10.2 Heat Map Analysis of Private Companies
    • 10.2.1 Company size
    • 10.2.2 Distribution network
    • 10.2.3 Product portfolio
    • 10.2.4 Segment coverage
    • 10.2.5 Geographic presence
    • 10.2.6 Collaborations
    • 10.2.7 Conclusion
  • 10.3 BD
    • 10.3.1 Company overview
    • 10.3.2 Financial performance
    • 10.3.3 Product benchmarking
    • 10.3.4 Strategic initiatives
  • 10.4 bioMerieux SA
    • 10.4.1 Company overview
    • 10.4.2 Financial performance
    • 10.4.3 Product benchmarking
    • 10.4.4 Strategic initiatives
  • 10.5 Abbott
    • 10.5.1 Company overview
    • 10.5.2 Financial performance
    • 10.5.3 Product benchmarking
    • 10.5.4 Strategic initiatives
  • 10.6 Quidel Corporation
    • 10.6.1 Company overview
    • 10.6.2 Financial performance
    • 10.6.3 Product benchmarking
    • 10.6.4 Strategic initiatives
  • 10.7 Alere Inc.
    • 10.7.1 Company overview
    • 10.7.2 Financial performance
    • 10.7.3 Product benchmarking
    • 10.7.4 Strategic initiatives
  • 10.8 ORASURE TECHNOLOGIES, INC
    • 10.8.1 Company overview
    • 10.8.2 Financial performance
    • 10.8.3 Product benchmarking
    • 10.8.4 Strategic initiatives
  • 10.9 Hologic, Inc. (Gen Probe)
    • 10.9.1 Company overview
    • 10.9.2 Financial performance
    • 10.9.3 Product benchmarking
    • 10.9.4 Strategic initiatives
  • 10.10 Cepheid
    • 10.10.1 Company overview
    • 10.10.2 Product benchmarking
    • 10.10.3 Strategic initiatives
  • 10.11 Qiagen N.V.
    • 10.11.1 Company Overview
    • 10.11.2 Financial performance
    • 10.11.3 Product benchmarking
    • 10.11.4 Strategic initiatives
  • 10.12 F. Hoffmann La-Roche Ltd.
    • 10.12.1 Company overview
    • 10.12.2 Financial performance
    • 10.12.3 Product benchmarking
    • 10.12.4 Strategic initiatives
  • 10.13 Siemens Healthcare GmbH
    • 10.13.1 Company overview
    • 10.13.2 Financial overview
    • 10.13.3 Product benchmarking
    • 10.13.4 Strategic initiatives
  • 10.14 Bio-Rad Laboratories, Inc.
    • 10.14.1 Company overview
    • 10.14.2 Financial overview
    • 10.14.3 Product benchmarking
    • 10.14.4 Strategic initiatives

List of Tables

  • TABLE 1 List of abbreviations
  • TABLE 2 North America IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 3 North America IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 4 North America IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 5 North America IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 6 North America IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 7 U.S. IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 8 U.S. IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 9 U.S. IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 10 U.S. IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 11 U.S. IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 12 Canada IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 13 Canada IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 14 Canada IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 15 Canada IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 16 Canada IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 17 Europe IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 18 Europe IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 19 Europe IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 20 Europe IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 21 Europe IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 22 U.K. IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 23 U.K. IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 24 U.K. IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 25 U.K. IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 26 U.K. IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 27 Germany IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 28 Germany IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 29 Germany IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 30 Germany IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 31 Germany IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 32 Spain IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 33 Spain IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 34 Spain IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 35 Spain IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 36 Spain IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 37 France IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 38 France IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 39 France IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 40 France IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 41 France IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 42 Italy IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 43 Italy IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 44 Italy IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 45 Italy IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 46 Italy IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 47 Asia Pacific IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 48 Asia Pacific IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 49 Asia Pacific IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 50 Asia Pacific IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 51 Asia Pacific IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 52 China IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 53 China IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 54 China IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 55 China IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 56 China IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 57 Japan IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 58 Japan IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 59 Japan IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 60 Japan IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 61 Japan IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 62 India IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 63 India IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 64 India IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 65 India IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 66 India IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 67 South Korea IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 68 South Korea IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 69 South Korea IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 70 South Korea IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 71 South Korea IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 72 Australia IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 73 Australia IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 74 Australia IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 75 Australia IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 76 Australia IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 77 Latin America IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 78 Latin America IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 79 Latin America IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 80 Latin America IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 81 Latin America IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 82 Brazil IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 83 Brazil IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 84 Brazil IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 85 Brazil IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 86 Brazil IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 87 Mexico IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 88 Mexico IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 89 Mexico IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 90 Mexico IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 91 Mexico IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 92 Argentina IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 93 Argentina IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 94 Argentina IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 95 Argentina IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 96 Argentina IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 97 MEA IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 98 MEA IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 99 MEA IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 100 MEA IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 101 MEA IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 102 South Africa IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 103 South Africa IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 104 South Africa IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 105 South Africa IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 106 South Africa IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 107 Saudi Arabia IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 108 Saudi Arabia IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 109 Saudi Arabia IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 110 Saudi Arabia IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 111 Saudi Arabia IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)
  • TABLE 112 UAE IVD infectious diseases market, by product, 2015 - 2027 (USD Million)
  • TABLE 113 UAE IVD infectious diseases market, by technology, 2015 - 2027 (USD Million)
  • TABLE 114 UAE IVD infectious diseases market, by application, 2015 - 2027 (USD Million)
  • TABLE 115 UAE IVD infectious diseases market, by end use, 2015 - 2027 (USD Million)
  • TABLE 116 UAE IVD infectious diseases product market, by application, 2015 - 2027 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Market summary
  • FIG. 4 Market segmentation & scope
  • FIG. 5 Market size and growth prospects
  • FIG. 6 Global IVD infectious diseases market - Key market driver analysis
  • FIG. 7 Global IVD infectious diseases market - Key market restraint analysis
  • FIG. 8 Penetration & growth prospect mapping
  • FIG. 9 Global IVD infectious diseases market - Porter's analysis
  • FIG. 10 Global IVD infectious diseases market - PESTEL analysis
  • FIG. 11 Global IVD infectious diseases market product outlook key takeaways
  • FIG. 12 Global IVD infectious diseases market: Product movement analysis
  • FIG. 13 Instruments market estimates, 2015 - 2027 (USD Billion)
  • FIG. 14 Reagents market estimates, 2015 - 2027 (USD Billion)
  • FIG. 15 Software market estimates, 2015 - 2027 (USD Billion)
  • FIG. 16 Global IVD infectious diseases market technology outlook key takeaways
  • FIG. 17 Global IVD infectious diseases market: Technology movement analysis
  • FIG. 18 Immunochemistry market estimates, 2015 - 2027 (USD Billion)
  • FIG. 19 Molecular diagnostics market estimates, 2015 - 2027 (USD Billion)
  • FIG. 20 Microbiology market estimates, 2015 - 2027 (USD Billion)
  • FIG. 21 Others market estimates, 2015 - 2027 (USD Billion)
  • FIG. 22 Global IVD infectious diseases market application outlook key takeaways
  • FIG. 23 Global IVD infectious diseases market: Application movement analysis
  • FIG. 24 MRSA market estimates, 2015 - 2027 (USD Billion)
  • FIG. 25 Streptococcus market estimates, 2015 - 2027 (USD Billion)
  • FIG. 26 Clostridium difficile market estimates, 2015 - 2027 (USD Billion)
  • FIG. 27 Vancomycin resistant enterococci market estimates, 2015 - 2027 (USD Billion)
  • FIG. 28 Carbapenem resistant bacterial testing market estimates, 2015 - 2027 (USD Billion)
  • FIG. 29 Respiratory virus market estimates, 2015 - 2027 (USD Billion)
  • FIG. 30 Candida market estimates, 2015 - 2027 (USD Billion)
  • FIG. 31 Tuberculosis and drug-resistant tuberculosis market estimates, 2015 - 2027 (USD Billion)
  • FIG. 32 Gastrointestinal panel testing market estimates, 2015 - 2027 (USD Billion)
  • FIG. 33 Chlamydia market estimates, 2015 - 2027 (USD Billion)
  • FIG. 34 Gonorrhea market estimates, 2015 - 2027 (USD Billion)
  • FIG. 35 HPV market estimates, 2015 - 2027 (USD Billion)
  • FIG. 36 HIV market estimates, 2015 - 2027 (USD Billion)
  • FIG. 37 Hepatitis C market estimates, 2015 - 2027 (USD Billion)
  • FIG. 38 Hepatitis B market estimates, 2015 - 2027 (USD Billion)
  • FIG. 39 Others market estimates, 2015 - 2027 (USD Billion)
  • FIG. 40 Global IVD infectious diseases market end use outlook key takeaways
  • FIG. 41 Global IVD infectious diseases market: End use movement analysis
  • FIG. 42 Point of care market estimates, 2015 - 2027 (USD Billion)
  • FIG. 43 Central laboratories market estimates, 2015 - 2027 (USD Billion)
  • FIG. 44 Regional market place: Key takeaways
  • FIG. 45 Global IVD infectious diseases market: Regional movement analysis
  • FIG. 46 North America IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 47 U.S. IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 48 Canada IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 49 Europe IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 50 U.K. IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 51 Germany IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 52 Spain IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 53 France IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 54 Italy IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 55 Asia Pacific IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 56 Japan IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 57 China IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 58 India IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 59 South Korea IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 60 Australia IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 61 Latin America IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 62 Brazil IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 63 Mexico IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 64 Argentina IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 65 MEA IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 66 South Africa IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 67 UAE IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 68 Saudi Arabia IVD infectious diseases market, 2015 - 2027 (USD Billion)
  • FIG. 69 Strategy framework